{
  "timestamp": "20250104_054308",
  "model": "gpt-4-turbo",
  "interaction_type": "answer_with_CoT",
  "question_id": "85d9c12a",
  "question_text": "Which of the following is not an action of epinephrine when administered intravenously in a high dose?",
  "messages": [
    {
      "role": "system",
      "content": "You are a medical expert using chain-of-thought reasoning."
    },
    {
      "role": "user",
      "content": "You are a medical expert specializing in the field of Pharmacology.\n            You are a medical expert determining the final answer.\n\n                ### Instructions:\n                - Use standard medical knowledge as the primary guide.\n                - Consider enhanced information only if it aligns with consensus.\n                - If conflicting or unclear, present the most likely correct answer based on known facts.\n                - It's acceptable to show moderate confidence if the question is complex, but still choose one best answer.\n            ### Question    \n            Which of the following is not an action of epinephrine when administered intravenously in a high dose?\n\n            ### Options\n            opa. Increases liver glycogenolysis\nopb. Causes broachiolar constriction\nopc. Evokes extrasystoles in the heart\nopd. Produces restlessness and anxiety\n\n### Reasoning Chains for Validation:\n- CHAIN: \"High dose of epinephrine\" -> \"activates beta-2 adrenergic receptors\" -> \"causes bronchiolar relaxation\" -> \"opposite of bronchiolar constriction\" -> 95%\n- CHAIN: \"High dose of epinephrine\" -> \"increases cyclic AMP in liver cells\" -> \"activates glycogen phosphorylase\" -> \"increases liver glycogenolysis\" -> 90%\n- CHAIN: \"High dose of epinephrine\" -> \"stimulates beta-1 adrenergic receptors in the heart\" -> \"increases heart rate and force of contraction\" -> \"can lead to extrasystoles\" -> 85%\n- CHAIN: \"High dose of epinephrine\" -> \"stimulates central nervous system\" -> \"can cause feelings of anxiety\" -> \"leads to restlessness and anxiety\" -> 90%\n\n### Retrieved Validation Paths:\n- (Epinephrine)-PART_OF->(Hepatocyte)\n- (Epinephrine)-INTERACTS_WITH->(Cells)-INTERACTS_WITH->(beta-2 Adrenergic Receptors)\n- (Epinephrine)-ASSOCIATED_WITH->(Pathogenesis)-ASSOCIATED_WITH->(beta-2 Adrenergic Receptors)\n- (Epinephrine)-INTERACTS_WITH->(Cells)-INTERACTS_WITH->(Receptors, Adrenergic, beta-1)\n- (Epinephrine)-PART_OF->(Adipocytes)-INTERACTS_WITH->(Receptors, Adrenergic, beta-1)\n- (Anxiety)-CAUSES->(Disease)-CAUSES->(Agitation)\n- (Anxiety)-CAUSES->(Hypertensive disease)-CAUSES->(Agitation)\n- (Anxiety)-CAUSES->(hypoglycemia)-CAUSES->(Agitation)\n- (cyclic AMP)-INTERACTS_WITH->(Progestins)-PART_OF->(Liver)-LOCATION_OF->(Glycogen Phosphorylase)\n- (Force)-CAUSES->(Spastic syndrome)-CAUSES->(Premature Cardiac Complex)\n- (Force)-CAUSES->(cardiac arrhythmia)-CAUSES->(Premature Cardiac Complex)\n- (Force)-CAUSES->(Ischemia)-CAUSES->(Premature Cardiac Complex)\n- (Contraction)-CAUSES->(Ventricular Fibrillation)-CAUSES->(Premature Cardiac Complex)\n\n            ### Task:\n                1. Identify the core medical principle and the most likely correct option based on consensus.\n                2. If the evidence is not perfectly clear, pick the best-supported option and explain the reasoning.\n                3. Provide a final analysis and a confidence score (0-100%).\n                \n                ### Output Format:\n                {\n                  \"final_analysis\": \"Step-by-step reasoning, prioritizing medical consensus and acknowledging complexity if present.\",\n                  \"answer\": \"Option key (e.g. opa, opb, ...)\",\n                  \"confidence\": A number between 0-100\n                }\n            "
    }
  ],
  "response": "### Core Medical Principle:\nEpinephrine, also known as adrenaline, is a catecholamine that acts on various adrenergic receptors throughout the body. These receptors include alpha and beta receptors, which mediate different physiological responses. The effects of epinephrine are dose-dependent and can vary based on the receptors predominantly activated at different concentrations.\n\n### Analysis of Options:\n1. **Increases liver glycogenolysis (opa)**: Epinephrine stimulates alpha and beta-2 adrenergic receptors in the liver, leading to increased cyclic AMP, which activates glycogen phosphorylase. This enzyme catalyzes the breakdown of glycogen into glucose, thereby increasing liver glycogenolysis. This is a well-documented effect of epinephrine.\n\n2. **Causes bronchiolar constriction (opb)**: Epinephrine primarily activates beta-2 adrenergic receptors in the bronchial smooth muscle, leading to bronchodilation, not constriction. This is a critical action, especially noted in the management of conditions like asthma where epinephrine is used to relieve bronchoconstriction.\n\n3. **Evokes extrasystoles in the heart (opc)**: By stimulating beta-1 adrenergic receptors in the heart, epinephrine increases the heart rate and the force of contraction. This can lead to extrasystoles, which are premature heartbeats originating from the ventricles. This effect is plausible, especially at higher doses.\n\n4. **Produces restlessness and anxiety (opd)**: Epinephrine has significant effects on the central nervous system, where it can increase alertness, cause anxiety, and induce feelings of restlessness. These are recognized psychological effects of epinephrine, particularly noticeable at higher doses.\n\n### Conclusion:\nBased on the analysis, the option that does not align with the known actions of epinephrine is **opb (Causes bronchiolar constriction)**. Epinephrine is known to cause bronchodilation, not constriction, which is a critical aspect of its therapeutic use in respiratory distress situations.\n\n### Final Analysis and Confidence Score:\nThe most likely correct answer, based on medical consensus and the pharmacological action of epinephrine, is that it does not cause bronchiolar constriction but rather induces bronchodilation. This conclusion is supported by the fundamental understanding of adrenergic receptor pharmacodynamics.\n\n```json\n{\n  \"final_analysis\": \"Epinephrine, when administered in high doses, acts on various adrenergic receptors. It is well-documented to cause bronchodilation through beta-2 adrenergic receptor activation, contrary to causing bronchiolar constriction. This understanding is crucial, especially in clinical settings where epinephrine is used to manage asthma and other respiratory conditions.\",\n  \"answer\": \"opb\",\n  \"confidence\": 95\n}\n```",
  "metadata": {
    "topic": "Pharmacology",
    "is_multi_choice": true,
    "has_reasoning_chain": true,
    "has_enhanced_info": true,
    "model_config": "gpt-4-turbo",
    "temperature": 0.0
  }
}